The International Forum for Drug and Alcohol Testing (IFDAT) is a non-profit organisation, dedicated to the advancement of global employee drug and alcohol testing systems and processes. In keeping with the international platform, the appointed Board Members and representatives of IFDAT cover a global reach. The “Annual” IFDAT Conference provides a platform for experts from a wide variety of disciplines associated with the drug and alcohol industries to meet and discuss a range of topics focused on current and future developments relevant to employee testing globally. In addition to World-class speakers, these conferences also provide an excellent networking opportunity.

2024 NDASA Conference and Trade Show

May 15 - May 17

Join us in Hershey, Pennsylvania for the largest conference for the drug and alcohol testing industry and its stakeholders. Information and registration are coming soon.

NDASA logo

The National Drug & Alcohol Screening Association (NDASA)
Phone: (888) 316-3272

The National Drug & Alcohol Screening Association (NDASA) is a member-owned, member-driven, member-operated organization whose mission is to advocate for safe and drug-free workplaces and communities through legislative advocacy, education, training, and excellence in drug and alcohol screening services. We offer a multitude of member benefits and discounts, keeping our members informed with weekly communications, a quarterly newsletter, a weekly podcast and Town Hall Meeting, monthly educational webinars, and an annual conference. Our training, certification, and accreditation programs are second to none. Member participation opportunities include committees, State Affiliates program, course re-seller training, promotions & sponsorships, and regional training events.

SAPAA logo

P.O. Box 6203
Tallahassee, FL 32314

The Substance Abuse Program Administrators (SAPAA) is the professional membership association representing the substance abuse testing and prevention industry, including third-party administrators, background screeners, specimen collectors, DERs, SAPs/EAPs, labs, MROs, device manufacturers, consultants, and government entities. SAPAA establishes, promotes, and communicates the highest standards of quality and integrity in the industry through education, training, and the exchange of ideas. SAPAA’s Training Institute provides specialized training concerning regulatory requirements, state issues, and industry trends and best practices. For more information, visit

AAMRO logo

P.O. Box 12873
Research Triangle Park, NC 27709
Phone: 1-800-489-1839

The American Association of Medical Review Officers, Inc. (AAMRO), was founded in 1991, as a medical society dedicated to establishing national standards and certification of medical practitioners and other professionals in the field of drug and alcohol testing. AAMRO has established standard practices and procedures, training programs, and administration of certification examinations. AAMRO is independent of existing medical membership groups and is designed to provide training and certification for physicians in different specialties.
AAMRO certification helps ensure the public’s receipt of quality services and the maintenance of ethical conduct by competent professionals involved in drug and alcohol testing.

The standards and certification process AAMRO has developed have been encouraged by, and are supported by federal agencies that are significantly involved in the procedural, policy, and administrative aspects of drug and alcohol testing.

Please Share Your Contact Details

A Quick Guide to Selecting a Drug Screening Provider

  1. What’s Inside Answers to ‘Why You Should Drug Test?’
  2. Your priorities vs providers strength.
  3. Considerations regarding ‘where’ and ‘when’ you do business.
  4. Discussion about the importance of third-party administrators.
  5. Discussion about Laboratories, MROs, and Collectors.

    Please Share Your Contact Details

    2022 In Search of X in Background Screening

    1. What’s Inside Most common reasons for implementing a policy and primary objectives.
    2. Written policy and examples of state requirements.
    3. Special policy considerations for states that have legalized use marijuana.
    4. Discussion of specimen types.
    5. Discussion of drug screening panels.
    6. Effective communication of policy.